Biotech China 2014

Drug Design: Eli Lilly

Total Score People Score Events Score
52 48 41
Date Event Presentation Speakers
November 2, 2009 Track 6: Third Annual Kinase Inhibitors Safety and Toxicology Challenges on the Way to a Kinase Inhibitor Drug Development Anja J. Stauber
October 13, 2009 Accelerating Proof of Concept Eli Lilly’s Chorus Program: The Continuing Evolution of Accelerated Drug Development Terri A. Roberson
August 5, 2009 New Frontiers in Cancer Drug Development Functional Definition of a Companion Diagnostic: Strategies for Fit-for-Purpose Development John C Bloom
June 10, 2009 Second Annual Hepatotoxicity and Drug Safety Early Prediction of Drug-Induced Hepatotoxicity. Where are We Now and Where are We Going? Arie Regev
KEYNOTE PANEL DISCUSSION Arie Regev
Chairperson’s Remarks Arie Regev
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Post-Hoc Comparison of Alternative Analytical Methods in the Non-Inferiority Comparison of Drug to Placebo in a thorough QT Study Charles M. Beasley
April 7, 2009 Kinase Inhibitor Chemistry - Charting the Chemical Space Exploiting Kinase Polypharmacology in Cell Cycle Regulation via High-Content Imaging Jeffrey Sutherland
February 24, 2009 11th National Conference on Managing Legal Risks in Structuring & Conducting Clinical Trials Complying With the FCPA & Overcoming Practical Constraints with Foreign Partners John F Kuckelman
February 23, 2009 4th Investigator Relationship Management CASE STUDY- IMPLEMENTING AN INVESTIGATOR-FRIENDLY EDC SYSTEM Jason Ridderikhoff
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Session 6: Chemistry in Support of Cancer Drug Discovery/Case Histories II Chuan Joe Shih
February 4, 2009 Adaptive Designs in Clinical Drug Development Chairman's Opening Remarks David Manner
OVERVIEW OF BAYESIAN ANALYSES USED IN ADAPTIVE DESIGNS David Manner
February 3, 2009 Ramanbhai Foundation 4th International Symposium ---Ramanbhai Foundation 4th International Symposium--- “Advances in Cardiometabolic Research - Basic Science and Clinical Aspects” “Beyond Small Molecules: The Use of Biologics in the Treatment of Metabolic Disorders” Richard D. DiMarchi
January 28, 2009 Electronic Laboratory Notebooks GREEN CHEMISTRY : Use of ELN for green science at Eli Lilly and Company Mike Kopach
January 27, 2009 6th Annual Clinical Trial Performance Metrics Reporting metrics – how to best use the metrics results that have been collected Jossy Matute
January 27, 2009 4th Annual Aseptic Filling and Processing Establishing an effective environmental monitoring programme to achieve quality and perfect compliance Mike Wassall
Isolator liquid filling technology: case study on a high speed line equipped with a PAT feature and integrated with MES Mauro Giusti
January 27, 2009 Forced Degradation Studies Oxidative Susceptibility Testing: Rapid, Comprehensive Screening Techniques Steve Baertschi
January 26, 2009 Biomarker Assay Development Utilizing a LC/MS/MS (MRM) Quantitative Targeted Biomarker Panel to Elucidate Multiple Biological Changes Simultaneously Jon Butler
January 26, 2009 7th Annual Partnering with Central Labs Chairperson’s Welcome Cynthia Lindemann
Risk Assessment : Current and Future Metrics Champion Consortium Metrics Initiatives David Rauh
Track B : Chairperson’s Opening Remarks David Rauh
Track B : Metrics Champion Consortium Imaging Performance Metrics Announcement David Rauh
Track C : Using the MCC ECG Metrics Steve Asbury
Chairperson’s Welcome Cynthia Lindemann
Track A : Overview of Metrics: Definition Refinement & Update from the Central Lab MCC Initiative Cynthia Lindemann
Track B : Chairperson’s Opening Remarks David Rauh
January 5, 2009 High Content Analysis Phenotypic Screening: A Complementary Drug Discovery Paradigm Jonathan A Lee
Application of High-Content Fingerprinting to Oncology Drug Discovery: Focus on in vitro and in vivo Phenocopying and Cancer Stem Cell Analysis Louis Stancato
December 2, 2008 The 8th World Drug Discovery & Development Summit 2008 HCS VS HTS – DEVELOPING A COMPLEMENTARY DRUG DISCOVERY MODEL Jonathan Lee
November 26, 2008 4th Annual Audits and Inspections for Clinical Trials and Pharmacovigilance Effective techniques to fulfil what the pharmacovigilance inspectors are looking for Noha Kassem,,
November 13, 2008 4th National Rx Drug Pricing Boot Camp Co-Chairs’ Opening Remarks Steven Benz
Managing the Operational Challenges of Government Prices: How to Get From Policy to Practice Steven Benz
November 12, 2008 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements Alliance Management: Establishing Governance Structures for Successful Collaborations Paul A Stewart
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Overview: Methods for Predicting Drug Toxicity During Development Jim Stevens
Relevance of In Vitro and In Vivo Models to Drug-induced Liver Injury Jim Stevens
ADME/PK Strategies for Small Molecules and Biotherapeutics Lisa A. Shipley
The Effect of Losing Multiple Clearance Pathways on Drug Safety and Viability Shelby Anderson
October 8, 2008 Accelerating Proof Of Concept Pharmaceutics During the Developability Phase: Is It Just About Speed? Jan Van Gelder
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Panel Discussion: Obstacles to Development--Ten Barriers to Proving Agents are Effective and Safe Richard B GAYNOR
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application Workshop: Can Industry and Academic Scientists Cooperate to Facilitate Drug Discovery? Gerard J. Marek
Novel GPCR Drugs in the Clinic Gerard J. Marek
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application (E2) Workshop: Can Industry and Academic Scientists Cooperate to Facilitate Drug Discovery? Gerard J. Marek
Novel GPCR Drugs in the Clinic Gerard J. Marek
December 3, 2007 PharmSep J. A Quality-by-Design Based Methodology for Quantitative Column and Solvent Screening in Rapid HPLC Method Development Joseph Turpin
December 3, 2007 Pharma Sep J. A Quality-by-Design Based Methodology for Quantitative Column and Solvent Screening in Rapid HPLC Method Development Joseph Turpin
November 28, 2007 Second Annual Portfolio Management: Creating a Portfolio for Optimal Productivity Nov (28-29) CASE STUDY: Portfolio Decisions with External Assets: A Case Study (15:50-16:30) Jay Andersen
November 15, 2007 Second Annual Drug Development India : Planning and Managing Drug Discovery & Development Activities Nov(15-16) STRATEGIES FOR PARTNERING AND OUTSOURCING (08:30-10:30) Rajiv Gulati
STRATEGIES FOR PARTNERING AND OUTSOURCING: Critical Components of Successful Entry Strategy (08:30-09:10) Rajiv Gulati
CONTRIBUTION OF ACADEMIC INSTITUTES (13:30-15:00) Brian K. Ramey
CONTRIBUTION OF ACADEMIC INSTITUTES: INTERACTIVE PANEL Supply Chain Challenges and Solutions to Reduce Cycle Time (14:20-15:00) Brian K. Ramey
PRECLINICAL DEVELOPMENT AND CHALLENGES (15:30-18:45) Rajiv Gulati
PRECLINICAL DEVELOPMENT AND CHALLENGES: INTERACTIVE PANEL :Partnership and Outsourcing Deals in India – Successes and Failures (17:00-17:45) Rajiv Gulati
CLINICAL DEVELOPMENT AND OPERATIONS (09:10-14:45) Vinod Mattoo
CLINICAL DEVELOPMENT AND OPERATIONS: INTERACTIVE PANEL:Outsourcing Globally and Executing International Trials in India (14:00-14:45) Vinod Mattoo
CLINICAL DEVELOPMENT AND OPERATIONS: Best Practices for Navigating the Clinical Landscape in India (09:10-09:50) Vinod Mattoo
November 7, 2007 Bridging the Business Development/Alliance Management Interface Nov(7-8) The Business Development - Alliance Management Interface at Lilly (09:30-10:15) Mark Barbato, Mark Miller
November 5, 2007 Bio-Pharma Alliance Summit Nov (05-06) The Challenges of Achieving Aligned Decision-making in Pharma/Biotech Collaborations - The ASAP/Humentum BioPharma Council’s Alliance Simulation Project (09:30-10:10) Michael Ransom
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 6: Systems Medicine Richard B GAYNOR
October 17, 2007 Inaugral Nuclear Harmone Receptors Modulators: Targets for Drug Discovery Oct (17-18) DISCOVERY CHEMISTRY (08:35-12:55) Matthew W. Carson, Timothy I. Richardson
DISCOVERY CHEMISTRY: Structure-Activity Relationships of Selective Estrogen Receptor Modulators (SERMs) Optimized for Uterine Antagonism and Ovarian Safety (11:55-12:25) Timothy I. Richardson
DISCOVERY CHEMISTRY: New Vistas in the Search for a Selective Glucocorticoid Receptor Modulator (SGRM) (09:40-10:10) Matthew W. Carson
October 15, 2007 2nd Annual Innovations in Clinical Trials: Implementations of Biomarkers (Oct15-16) BIOIMAGING FOR MONITORING RESPONSE TO THERAPY, DOSE SELECTION, ASSESSING MOLECULAR ACTIVITY AND RECEPTOR OCCUPANCY (08:00-13:30) Loretta McQuaid
Use of Imaging in Support of Tailored Therapeutics (08:35-09:05) Loretta McQuaid
October 15, 2007 Cambridge Healthtech Institute's Third Annual Mastering Process Chemistry Oct (15-17) STRATEGIZING FOR COMMERCIAL SUCCESS: Case Study of Outsourcing Process Chemistry (11:30-12:00) David Mitchell
STRATEGIZING FOR COMMERCIAL SUCCESS (09:40-12:30) David Mitchell
BIOCATALYSIS FOR CHEMICAL PROCESS DEVELOPMENT (08:55-12:00) David Mitchell
BIOCATALYSIS FOR CHEMICAL PROCESS DEVELOPMENT: Moderated Panel Discussion (11:00-12:00) David Mitchell
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) PROFILING TO OPTIMIZE EFFICACY (08:30-14:00) Jeffrey J. Sutherland
PROFILING TO OPTIMIZE EFFICACY: Prioritizing Hits from Phenotypic Assays Using Biochemical Profiling Data (10:45-11:15) Jeffrey J. Sutherland
September 24, 2007 12th Annual Drug Delivery Technologies & Deal Making Track B: Drug Delivery Partnering - A Eli Insight on the Pharma Outlook: Past, Present, & the Future Snehlata Mascarenhas
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part II Emerging Technology Platforms for Biomarker Assay Development in the Clinical Setting (13:30-14:00) Sunil Kadam
September 10, 2007 Drug Development In China: Strategies for launching Discovery and Development activities OPENING KEYNOTES: Pharmaceutical R&D in China: Leveraging Collaboration & Managing Risk for Maximum Value (09:45 - 10:30) Guoxin Zhu
OPENING KEYNOTES (09:00 - 11:45) Guoxin Zhu
OPENING KEYNOTES: Interactive Panel Discussion #1 (11:45 - 12:30) Guoxin Zhu
Interactive Panel Discussion #2 (16:45 - 17:45) Rajiv Gulati
Interactive Panel Discussion#3 (11:30-12:15) Guoxin Zhu
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.